Clotrimazole: a review of its antifungal activity and therapeutic efficacy.
about
Antifungal agents for the treatment of mucocutaneous candidiasis in neonates and childrenThe human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactionsDesign of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressantDelineation of the clotrimazole/TRAM-34 binding site on the intermediate conductance calcium-activated potassium channel, IKCa1Polymer Encapsulation of an Amorphous Pharmaceutical by initiated Chemical Vapor Deposition for Enhanced StabilityPrevention of red cell dehydration: a possible new treatment for sickle cell disease.Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans.Therapy of fungal infectionsEvidence for a protective role of the Gardos channel against hemolysis in murine spherocytosis.Potent antimalarial activity of clotrimazole in in vitro cultures of Plasmodium falciparum.Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease.The antifungal antibiotic, clotrimazole, inhibits Cl- secretion by polarized monolayers of human colonic epithelial cells.The antifungal antibiotic, clotrimazole, inhibits chloride secretion by human intestinal T84 cells via blockade of distinct basolateral K+ conductances. Demonstration of efficacy in intact rabbit colon and in an in vivo mouse model of cholera.Azole antifungals: 35 years of invasive fungal infection management.Yeast caspase-dependent apoptosis in Saccharomyces cerevisiae BY4742 induced by antifungal and potential antitumor agent clotrimazole.Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives.Antiviral screening identifies adenosine analogs targeting the endogenous dsRNA Leishmania RNA virus 1 (LRV1) pathogenicity factor.Effect of fatty acyl group and sterol composition on sensitivity of lecithin liposomes to imidazole antimycotics.Effect of clotrimazole on the pump cycle of the Na,K-ATPase.Morphologies in Solvent-Annealed Clotrimazole Thin Films Explained by Hansen-Solubility Parameters.Fluid bed drying of guarana (Paullinia cupana HBK) extract: effect of process factors on caffeine content.Design, synthesis, and biological evaluation of hydroquinone derivatives as novel inhibitors of the sarco/endoplasmic reticulum calcium ATPase.Wrinkle formation in a polymeric drug coating deposited via initiated chemical vapor deposition.Clinical comparison of the efficacy and tolerability of once daily Canesten with twice daily Nizoral (clotrimazole 1% cream vs. ketoconazole 2% cream) during a 28-day topical treatment of interdigital tinea pedis.Novel approaches to treatment of sickle cell anaemia.Design and optimization of surfactant-based nanovesicles for ocular delivery of Clotrimazole.Clotrimazole inhibits hemoperoxidase of Plasmodium falciparum and induces oxidative stress. Proposed antimalarial mechanism of clotrimazole.Formulation and in vitro evaluation of carbopol 934-based modified clotrimazole gel for topical application.Comparison of the ligand binding site of CYP2C8 with CYP26A1 and CYP26B1: a structural basis for the identification of new inhibitors of the retinoic acid hydroxylases.
P2860
Q24246877-A8130FF5-3F5D-42DA-BB71-4BAE51CD1CADQ24310512-4A281CCF-48FE-4C7F-9814-B485D46A7481Q24675998-A240F520-95F7-4443-B4B2-ED98E042BC58Q28203719-A5E87782-BA46-4257-B4FC-EAA852BF4397Q28828863-C31D26FB-263B-418A-9323-8A3244CBD113Q35098089-93E62284-84B1-4CB2-AC1D-F3C6657DC05DQ35572405-765F7444-94C3-482F-9F3E-B473C63D571FQ35651619-D02D21A5-E2EB-47C3-9B43-BFA161F89F70Q35848022-4F86128C-71A6-4C87-9641-C0C5348713F1Q37152163-5C46E79F-4971-4333-A534-AEC285E477EDQ37352493-DE71FB2D-3A56-4009-8F40-5B8B67EC3759Q37361151-B8B684C8-7768-41E3-A0BE-AF8AD07C6512Q37376569-F25CBD35-1B88-4FF7-B5E1-DEA24AF29C5EQ38406393-1590FA09-2E1A-40F9-BFCD-FFBEC1C380B3Q40088744-0F64C9A5-4786-4ABA-803C-A96F4CAF951CQ40333068-5C4AEF4E-DD32-4233-BC7A-43D9C376E1C2Q40368500-B7123B4B-6D22-4A83-8860-FE9433D196EEQ40620473-A38A2B1E-0B3A-4C8E-AAF5-431DC126F1C1Q40897001-26755605-194F-4D79-B4AE-79210E111DD8Q41893508-1757283B-990E-470C-96F8-EB197CF2D8D1Q41990123-71CA527F-7B93-4785-A227-8F3A8426A5CCQ42137898-05CF5210-007D-4B04-8D1C-84C801D2FCF7Q42320828-CAE66A44-9783-475D-9E8A-FB215D93362EQ43986538-E4992BDE-FA39-4E24-8C91-F1B8AFF87DDCQ45873795-6E4AE6FA-1251-44E8-9E41-F2A1E1CDFDC1Q45889086-8FAF92CF-48C3-4D7E-9E67-B1F7248ABBB1Q46465773-414006ED-E421-4072-A059-94232EB7494DQ50538802-E784490F-6376-4D31-BB41-A14E2B0CBB55Q51636744-0ED54DF3-E4BF-4BEE-A014-992DB7F71682
P2860
Clotrimazole: a review of its antifungal activity and therapeutic efficacy.
description
1975 nî lūn-bûn
@nan
1975 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
Clotrimazole: a review of its antifungal activity and therapeutic efficacy.
@ast
Clotrimazole: a review of its antifungal activity and therapeutic efficacy.
@en
Clotrimazole: a review of its antifungal activity and therapeutic efficacy.
@nl
type
label
Clotrimazole: a review of its antifungal activity and therapeutic efficacy.
@ast
Clotrimazole: a review of its antifungal activity and therapeutic efficacy.
@en
Clotrimazole: a review of its antifungal activity and therapeutic efficacy.
@nl
prefLabel
Clotrimazole: a review of its antifungal activity and therapeutic efficacy.
@ast
Clotrimazole: a review of its antifungal activity and therapeutic efficacy.
@en
Clotrimazole: a review of its antifungal activity and therapeutic efficacy.
@nl
P2093
P1433
P1476
Clotrimazole: a review of its antifungal activity and therapeutic efficacy.
@en
P2093
P304
P356
10.2165/00003495-197509060-00003
P577
1975-01-01T00:00:00Z
P6179
1038681145